An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma. Anota, A.; Boulin, M.; Dabakuyo-Yonli, S.; Hillon, P.; Cercueil, J. P.; Minello, A.; Jouve, J. L.; Paoletti, X.; Bedenne, L.; Guiu, B.; Bonnetain, F.. BMJ Open. 2016; e010696: p.e010696. doi:10.1136/bmjopen-2015-010696 10.1136/bmjopen-2015-010696.Article
Oncostat